Pathogenic sphingosine 1-phosphate pathway in psoriasis: a critical review of its pathogenic significance and potential as a therapeutic target

WHO. Global report on psoriasis. Geneva: World Health Organization; 2016.

Google Scholar 

Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. psoriasis. Lancet. 2021;397(10281):1301–15. https://doi.org/10.1016/S0140-6736(20)32549-6. PMID: 33812489.

Article  CAS  PubMed  Google Scholar 

Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. Psoriasis risk factors and triggers. Cutis. 2018;102(5S):18–20. PMID: 30566552.

PubMed  Google Scholar 

Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475. https://doi.org/10.3390/ijms20061475. PMID:30909615;PMCID:PMC6471628.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu J, Zhao Q, Wang X, Zhou H, Hu J, Gu L, Hu Y, Zeng F, Zhao F, Yue C, Zhou P, Li G, Li Y, Wu W, Zhou Y, Li J. Pathogenesis, multi-omics research, and clinical treatment of psoriasis. J Autoimmun. 2022;133:102916. https://doi.org/10.1016/j.jaut.2022.102916. epub ahead of print. pmid: 36209691.

Article  CAS  PubMed  Google Scholar 

Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–71. https://doi.org/10.1016/S0140-6736(07)61128-. PMID: 17658397.

Article  CAS  PubMed  Google Scholar 

Machado-Pinto J, Diniz Mdos S, Bavoso NC. Psoriasis: new comorbidities. An Bras Dermatol. 2016;91(1):8–14. https://doi.org/10.1590/abd1806-4841.20164169. PMID: 26982772; PMCID: PMC4782640.

Article  PubMed  PubMed Central  Google Scholar 

Pinschewer DD, Brinkmann V, Merkler D. Impact of sphingosine 1-phosphate modulation on immune outcomes. Neurology. 2011;76(8 Suppl 3):S15–9. https://doi.org/10.1212/WNL.0b013e31820d9596. PMID: 21339486.

Article  CAS  PubMed  Google Scholar 

Don-Doncow N, Zhang Y, Matuskova H, Meissner A. The emerging alliance of sphingosine-1-phosphate signalling and immune cells: from basic mechanisms to implications in hypertension. Br J Pharmacol. 2019;176(12):1989–2001. https://doi.org/10.1111/bph.14381. Epub 2018 Jul 3. PMID: 29856066; PMCID: PMC6534782.

Article  CAS  PubMed  Google Scholar 

Verstockt B, Vetrano S, Salas A, Nayeri S, Duijvestein M, Vande Casteele N, Alimentiv Translational Research Consortium (ATRC). Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2022;19(6):351–66. https://doi.org/10.1038/s41575-021-00574-7. Epub 2022 Feb 14. Erratum in: Nat Rev Gastroenterol Hepatol. 2022. PMID: 35165437.

Article  CAS  PubMed  Google Scholar 

Weigel C, Maczis MA, Palladino END, Green CD, Maceyka M, Guo C, Wang XY, Dozmorov MG, Milstien S, Spiegel S. Sphingosine Kinase 2 in stromal fibroblasts creates a hospitable tumor microenvironment in breast cancer. Cancer Res. 2023;83(4):553–67. https://doi.org/10.1158/0008-5472.CAN-22-1638. PMID:36541910;PMCID:PMC9931683.

Article  CAS  PubMed  Google Scholar 

Kleuser B, Bäumer W. Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases. Int J Mol Sci. 2023;24(2):1456. https://doi.org/10.3390/ijms24021456. PMID:36674974;PMCID:PMC9863039.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baeyens A, Bracero S, Chaluvadi VS, Khodadadi-Jamayran A, Cammer M, Schwab SR. Monocyte-derived S1P in the lymph node regulates immune responses. Nature. 2021;592(7853):290–5. https://doi.org/10.1038/s41586-021-03227-6. Epub 2021 Mar 3. PMID: 33658712; PMCID: PMC8475585.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Checa A, Xu N, Sar DG, Haeggström JZ, Ståhle M, Wheelock CE. Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment. Sci Rep. 2015;5:12017. https://doi.org/10.1038/srep12017. PMID:26174087;PMCID:PMC4502512.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kozłowska D, Harasim-Symbor E, Myśliwiec H, Milewska A, Chabowski A. Serum sphingolipid level in psoriatic patients with obesity. Postepy Dermatol Allergol. 2019;36:714–21.

Article  Google Scholar 

Fyrst H, Saba JD. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol. 2010;6(7):489–97. https://doi.org/10.1038/nchembio.392.

Chalfant CE, Spiegel S. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci. 2005;118(Pt 20):4605–12. https://doi.org/10.1242/jcs.02637. PMID: 16219683.

Article  CAS  PubMed  Google Scholar 

Cannavo A, Liccardo D, Komici K, Corbi G, de Lucia C, Femminella GD, Elia A, Bencivenga L, Ferrara N, Koch WJ, Paolocci N, Rengo G. Sphingosine kinases and sphingosine 1-phosphate receptors: signaling and actions in the cardiovascular system. Front Pharmacol. 2017;8:556. https://doi.org/10.3389/fphar.2017. PMID: 28878674; PMCID: PMC5572949.

Article  PubMed  PubMed Central  Google Scholar 

Kuang Y, Li X, Liu X, Wei L, Chen X, Liu J, Zhuang T, Pi J, Wang Y, Zhu C, Gong X, Hu H, Yu Z, Li J, Yu P, Fan H, Zhang Y, Liu Z, Zhang L. Vascular endothelial S1pr1 ameliorates adverse cardiac remodelling via stimulating reparative macrophage proliferation after myocardial infarction. Cardiovasc Res. 2021;117(2):585–99. https://doi.org/10.1093/cvr/cvaa046. pmid:32091582.

Article  CAS  PubMed  Google Scholar 

Ganbaatar B, Fukuda D, Shinohara M, Yagi S, Kusunose K, Yamada H, Soeki T, Hirata KI, Sata M. Inhibition of S1P receptor 2 attenuates endothelial dysfunction and inhibits atherogenesis in apolipoprotein E-deficient mice. J Atheroscler Thromb. 2021;28(6):630–42. https://doi.org/10.5551/jat.54916. Epub 2020 Sep 2. PMID: 32879149; PMCID: PMC8219539.

Article  CAS  PubMed  Google Scholar 

van Doorn R, Lopes Pinheiro MA, Kooij G, Lakeman K, van het Hof B, van der Pol SM, Geerts D, van Horssen J, van der Valk P, van der Kam E, Ronken E, Reijerkerk A, de Vries HE. Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier. J Neuroinflammation. 2012;9:133. https://doi.org/10.1186/1742-2094-9-133. PMID:22715976;PMCID:PMC3425155.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeon S, Song J, Lee D, Kim GT, Park SH, Shin DY, Shin KO, Park K, Shim SM, Park TS. Inhibition of sphingosine 1-phosphate lyase activates human keratinocyte differentiation and attenuates psoriasis in mice. J Lipid Res. 2020;61(1):20–32. https://doi.org/10.1194/jlr.RA119000254. epub 2019 Nov 5. PMID: 31690639; PMCID: PMC6939600.

Article  CAS  PubMed  Google Scholar 

Patil MJ, Meeker S, Bautista D, Dong X, Undem BJ. Sphingosine-1-phosphate activates mouse vagal airway afferent C-fibres via S1PR3 receptors. J Physiol. 2019;597(7):2007–19. https://doi.org/10.1113/JP277521. Epub 2019 Feb 21. PMID: 30793318; PMCID: PMC6441905.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Syed SN, Raue R, Weigert A, von Knethen A, Brüne B. Macrophage S1PR1 Signaling Alters Angiogenesis and Lymphangiogenesis During Skin Inflammation. Cells. 2019;8(8):785. https://doi.org/10.3390/cells8080785.

Ni X, Lai Y. Keratinocyte: A trigger or an executor of psoriasis? J Leukoc Biol. 2020;108(2):485–91. https://doi.org/10.1002/JLB.5MR0120-439R. Epub 2020 Mar 14. pmid: 32170886.

Article  CAS  PubMed  Google Scholar 

Naik S, Larsen SB, Gomez NC, Alaverdyan K, Sendoel A, Yuan S, Polak L, Kulukian A, Chai S, Fuchs E. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature. 2017;550(7677):475–80. https://doi.org/10.1038/nature24271.

Masuda-Kuroki K, Di Nardo A. Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface. Biology (Basel). 2022;11(6):809. https://doi.org/10.3390/biology11060809. PMID:35741330;PMCID:PMC9219813.

Article  CAS  PubMed  Google Scholar 

Kim DS, Kim SY, Kleuser B, Schäfer-Korting M, Kim KH, Park KC. Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt/protein kinase B inactivation. Cell Signal. 2004;16(1):89–95. https://doi.org/10.1016/s0898-6568(03)00114-1. PMID: 14607279.

Article  CAS  PubMed  Google Scholar 

Lichte K, Rossi R, Danneberg K, ter Braak M, Kürschner U, Jakobs KH, Kleuser B, Meyer zu Heringdorf D. Lysophospholipid receptor-mediated calcium signaling in human keratinocytes. J Invest Dermatol. 2008;128(6):1487–98. https://doi.org/10.1038/sj.jid.5701207. epub 2008 Jan 3. PMID: 18172456.

Article  CAS  PubMed  Google Scholar 

Moriue T, Igarashi J, Yoneda K, Hashimoto T, Nakai K, Kosaka H, Kubota Y. Sphingosine 1-phosphate attenuates peroxide-induced apoptosis in HaCaT cells cultured in vitro. Clin Exp Dermatol. 2013;38(6):638–45. https://doi.org/10.1111/ced.12037. epub 2013 Mar 21. pmid: 23837937.

Article  CAS  PubMed  Google Scholar 

Hammer S, Sauer B, Spika I, Schraut C, Kleuser B, Schäfer-Korting M. Glucocorticoids mediate differential anti-apoptotic effects in human fibroblasts and keratinocytes via sphingosine-1-phosphate formation. J Cell Biochem. 2004;91(4):840–51. https://doi.org/10.1002/jcb.10766.pmid:14991774.

Article  CAS  PubMed  Google Scholar 

Uchida Y, Houben E, Park K, Douangpanya S, Lee YM, Wu BX, Hannun YA, Radin NS, Elias PM, Holleran WM. Hydrolytic pathway protects against ceramide-induced apoptosis in keratinocytes exposed to UVB. J Invest Dermatol. 2010;130(10):2472–80. https://doi.org/10.1038/jid.2010.153. Epub 2010 Jun 3 PMID: 20520628.

Article  CAS  PubMed  Google Scholar 

Schmitz EI, Potteck H, Schüppel M, Manggau M, Wahydin E, Kleuser B. Sphingosine 1-phosphate protects primary human keratinocytes from apoptosis via nitric oxide formation through the receptor subtype S1P3. Mol Cell Biochem. 2012;371(1–2):165–76. https://doi.org/10.1007/s11010-012-1433-5. Epub 2012 Aug 17 PMID: 22899173.

Article  CAS  PubMed  Google Scholar 

Oizumi A, Nakayama H, Okino N, Iwahara C, Kina K, Matsumoto R, Ogawa H, Takamori K, Ito M, Suga Y, Iwabuchi K. Pseudomonas-derived ceramidase induces production of inflammatory mediators from human keratinocytes via sphingosine-1-phosphate. PLoS One. 2014;9(2):e89402. https://doi.org/10.1371/journal.pone.0089402. PMID: 24586752; PMCID: PMC3934885.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakahara T, Kido-Nakahara M, Ulzii D, Miake S, Fujishima K, Sakai S, Chiba T, Tsuji G, Furue M. Topical application of endothelin receptor a antagonist attenuates imiquimod-induced psoriasiform skin inflammation. Sci Rep. 2020;10(1):9510. https://doi.org/10.1038/s41598-020-66490-z. PMID:32528072;PMCID:PMC7289852.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torii H, Nakagawa H, Japanese Infliximab Study Investigators. Long-term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis

留言 (0)

沒有登入
gif